$1.75
0.1610.26%
Last update: Nov 9, 2:31 PM
BioHarvest Sciences Inc
BHSTNASDAQ
The average analyst price target for BioHarvest Sciences is $9, 413.4% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $5 to $14. The latest change came on Aug 12, 2026, when Maxim Group lowered its price target on BioHarvest Sciences from $12 to $5 and kept a Buy rating.
Price Target Range — 4 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
